Insiders sold $1.8M in the last 30 days, all through pre-planned sales
Institutions cut 1.9% from their holdings in the quarter ending June 2026 (185 bought, 96 sold)
Held by Chase Coleman (Tiger Global)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$28.56-3.5% that day
Company value
$11.2B
Share price times all shares
Price vs profit (P/E)
32.5x
You pay about $32 for each $1 of yearly profit
Price vs sales
4.6x
Company value is 4.6 times a year of sales
Cash vs value
5%
Cash as a share of company value
From CHYM's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 10 quarters, from SEC filings
Sales, Jun '26
$669.8M+27% vs a year earlier
Mar '24Tap a barJun '26
Last 12 months: $2.5B, up 26% from the 12 months before.
What the price assumes
Your guesses, our math
Move the sliders to your own view of CHYM. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$7.8B
Profit in 5 years$780M
Price these guesses point to$63.47+122% vs $28.56 todayAbout +17% a year, before dividends
What today's price needs: with a 10% margin and a 32x P/E, sales would have to grow about 7.4% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
The checklist Warren Buffett-style investors use. Annual numbers for 2025.
2/3Mixed
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-46.2%
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$52.8M
Revenue
$2.2B
+30.7% vs prior year
Total debt
None
0.00x equity
Free cash flow
$52.8M
2.4% of revenue
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: return on equity 15%+, profitable every year, share count not growing. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026
Reported Aug 5
Revenue
$669.8M
+26.8% YoY
EPS
$0.07
vs -$2.43
Op. margin
3.2%
+179.4 pts
Gross margin
88.8%
+1.5 pts
Free cash flow
$197.5M
Share count
+3.6%
vs a year ago
Insider rating
Last 90 days
44Mixed
Pre-planned sales of $1.8M (weaker signal)
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
Weekly insider trend
13 weeks agoBoughtSoldThis week
Filing buzz
Last 7 days vs normal
13/ 100
This week
1
Normal week
5.0
vs normal
0.2x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-1.9%
Institutions cut 1.9% from their holdings. 185 bought, 96 sold. 2 quarters of net selling in a row.
Shares held by institutions289.7M
Sep '24Jun '26
Safety check
From SEC filings
Cash runwayAt last year's cash burn
Cash flow positive
Debt to equityLatest balance sheet: debt compared with what owners have
No debt reported
Shares outstandingLatest reported
393M
Why moderate risk
Losing money, losses are large next to sales
Earnings reports
Last 5
Next reportIn 7 days (est.)Estimated from the same quarter last year
Results filedAug 5
Results filedMay 6
Results filedFeb 25
Results filedNov 5, 2025
Results filedAug 7, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days